Abbott Laboratories (ABT)
Gross profit margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit (ttm) | US$ in thousands | 23,320,000 | 22,546,000 | 22,147,000 | 21,835,000 | 21,724,000 | 21,964,000 | 22,207,000 | 23,036,000 | 24,511,000 | 25,715,000 | 26,439,000 | 25,391,000 | 24,538,000 | 24,044,000 | 22,426,000 | 21,215,000 | 19,605,000 | 18,277,000 | 18,108,000 | 18,743,000 |
| Revenue (ttm) | US$ in thousands | 41,950,000 | 41,217,000 | 40,725,000 | 40,326,000 | 40,109,000 | 39,959,000 | 40,226,000 | 41,505,000 | 43,653,000 | 45,030,000 | 45,548,000 | 44,514,000 | 43,075,000 | 42,308,000 | 40,233,000 | 37,338,000 | 34,608,000 | 32,221,000 | 31,444,000 | 32,095,000 |
| Gross profit margin | 55.59% | 54.70% | 54.38% | 54.15% | 54.16% | 54.97% | 55.21% | 55.50% | 56.15% | 57.11% | 58.05% | 57.04% | 56.97% | 56.83% | 55.74% | 56.82% | 56.65% | 56.72% | 57.59% | 58.40% |
December 31, 2024 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $23,320,000K ÷ $41,950,000K
= 55.59%
Abbott Laboratories' gross profit margin has displayed some fluctuations over the period from March 31, 2020, to December 31, 2024. The margin started at a strong level of 58.40% in March 2020, showing robust profitability on sales. However, there was a slight decline by June 2020 to 57.59%, which continued to decrease gradually over the following quarters.
By December 2020, the gross profit margin stood at 56.65%, demonstrating a slight decrease in profitability. The trend continued with minor fluctuations until June 2021 when it dropped to 55.74%, signifying a more significant decline in profitability relative to the starting point.
Despite the fluctuations, there was a modest recovery in the margin in the subsequent quarters. Notably, by June 2022, the gross profit margin reached a peak of 58.05%, indicating improved profitability on sales. However, this increase was not sustained, as the margin started to decline again in the following quarters.
By the end of December 2024, Abbott Laboratories' gross profit margin was recorded at 55.59%. This figure represented a moderate increase compared to the previous quarter, suggesting some stability in profitability levels. Overall, the gross profit margin trend for Abbott Laboratories shows fluctuations over the analyzed period, with both peaks and troughs impacting the company's profitability on sales.
Peer comparison
Dec 31, 2024